Bio-Techne Current Liabilities
The Current Liabilities of Bio-Techne (TECH) as of Sep 3, 2026 is 160.11 M USD. In the previous year, Current Liabilities was 238.06 M USD — a change of -32.75% (lower).
Get this data via API
Financial Data API
Current Liabilities
160.11 MUSD
YoY
-32.75%
Last updated:
The Bio-Techne Current Liabilities history
3 Years
10 Years
25 Years
Max
| YEAR | Current Liabilities | YoY |
|---|---|---|
| 160.11 MUSD | -32.75% | |
| 238.06 MUSD | +10.54% | |
| 215.37 MUSD | +37.86% | |
| 156.22 MUSD | -35.89% | |
| 243.67 MUSD | +11.44% | |
| 218.65 MUSD | +42.50% | |
| 153.44 MUSD | -0.77% | |
| 154.64 MUSD | +32.48% | |
| 116.72 MUSD | -34.60% | |
| 178.47 MUSD | +139.08% | |
| 74.65 MUSD | +34.95% | |
| 55.32 MUSD | +52.83% | |
| 36.20 MUSD | -16.62% | |
| 43.41 MUSD | +16.69% | |
| 37.20 MUSD | +84.35% | |
| 20.18 MUSD | +17.40% | |
| 17.19 MUSD | +11.06% | |
| 15.48 MUSD | -46.33% | |
| 28.84 MUSD | +24.34% | |
| 23.19 MUSD | -4.42% | |
| 24.27 MUSD | +20.63% | |
| 20.12 MUSD | +10.78% | |
| 18.16 MUSD | +31.51% | |
| 13.81 MUSD | -25.48% | |
| 18.53 MUSD | -2.94% | |
| 19.09 MUSD | +16.69% | |
| 16.36 MUSD | +3.55% | |
| 15.80 MUSD | +68.09% | |
| 9.40 MUSD | +40.30% | |
| 6.70 MUSD | +0.00% | |
| 6.70 MUSD | +21.82% | |
| 5.50 MUSD | +17.02% | |
| 4.70 MUSD | +30.56% | |
| 3.60 MUSD | +5.88% | |
| 3.40 MUSD | +17.24% | |
| 2.90 MUSD | +16.00% | |
| 2.50 MUSD | +25.00% | |
| 2.00 MUSD | — |
Bio-Techne Stock analysis
Frequently Asked Questions about Bio-Techne stock
Current Liabilities of Bio-Techne is 160.11 M USD in 2026.
Current Liabilities of Bio-Techne changed from 238.06 M USD to 160.11 M USD, representing a -32.75% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Current Liabilities Bio-Techne since 2006 – with annual values, charts, and detailed analysis.
Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.
Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Bio-Techne historically and in real time.
Balance Sheet — Bio-Techne
All Key Metrics — Bio-Techne
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth